AKT1 and cancer: Additionally, activation of the phosphatidylinositol-3 kinase (PI3K)–Akt pathway also reportedly induces PD-L1, and the loss-of-function mutation of phosphatase and tensin homolog deleted from chromosome 10 (PTEN), a regulator of the PI3K–Akt pathway, is associated with the expression of PD-L1 in cancer [31,32].